Mingjian Ding

461 total citations
17 papers, 379 citations indexed

About

Mingjian Ding is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Mingjian Ding has authored 17 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Plant Science. Recurrent topics in Mingjian Ding's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Mingjian Ding is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Mingjian Ding collaborates with scholars based in China and Australia. Mingjian Ding's co-authors include Xiaodong Cong, Shenglin Ma, Yin Dai, Wenzhe Wang, De‐Zai Dai, Xiaoju Wang, Liang Chen, You Wu, Weili Li and Yun Zhang and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Mingjian Ding

17 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjian Ding China 12 241 151 60 36 29 17 379
Élisabeth Miot-Noirault France 10 157 0.7× 73 0.5× 69 1.1× 41 1.1× 22 0.8× 15 368
Juan Zou China 13 220 0.9× 51 0.3× 87 1.4× 26 0.7× 32 1.1× 30 405
Xiaoguo H. Zhan United States 9 336 1.4× 95 0.6× 133 2.2× 26 0.7× 44 1.5× 9 715
Jin Cao China 10 256 1.1× 208 1.4× 46 0.8× 15 0.4× 20 0.7× 14 440
Yong‐Tark Jeon South Korea 9 225 0.9× 138 0.9× 109 1.8× 15 0.4× 54 1.9× 16 431
Eun-Yeong Kim South Korea 13 239 1.0× 155 1.0× 48 0.8× 33 0.9× 70 2.4× 24 448
Xiu Cheng China 12 264 1.1× 179 1.2× 53 0.9× 21 0.6× 73 2.5× 29 528
Tong Xu China 9 193 0.8× 107 0.7× 57 0.9× 18 0.5× 27 0.9× 24 338

Countries citing papers authored by Mingjian Ding

Since Specialization
Citations

This map shows the geographic impact of Mingjian Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjian Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjian Ding more than expected).

Fields of papers citing papers by Mingjian Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjian Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjian Ding. The network helps show where Mingjian Ding may publish in the future.

Co-authorship network of co-authors of Mingjian Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjian Ding. A scholar is included among the top collaborators of Mingjian Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjian Ding. Mingjian Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ding, Mingjian, et al.. (2023). Has_circ_0048764 promotes breast cancer progression by sponging miR-578 and regulating HMGA2 expression. Nucleosides Nucleotides & Nucleic Acids. 42(6). 448–463. 5 indexed citations
2.
Liu, Jinzhao, Yifei Li, Weifang Zhang, et al.. (2022). The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis. Frontiers in Surgery. 9. 971030–971030. 9 indexed citations
3.
Ding, Mingjian, et al.. (2020). A cell line development strategy to improve a bispecific antibody expression purity in CHO cells. Biochemical Engineering Journal. 166. 107857–107857. 11 indexed citations
4.
Chen, Liang, et al.. (2020). A Novel Synthesis of Fe3O4@SiO2@Au@Porous SiO2 Structure for NIR Irradiation-Induced DOX Release and Cancer Treatment. Dose-Response. 18(1). 3584355494–3584355494. 10 indexed citations
5.
Ding, Mingjian, et al.. (2020). MicroRNA‐124‐3p.1 promotes cell proliferation through Axin1‐dependent Wnt signaling pathway and predicts a poor prognosis of triple‐negative breast cancer. Journal of Clinical Laboratory Analysis. 34(7). e23266–e23266. 27 indexed citations
6.
Shi, Dongliang, et al.. (2019). <p>MicroRNA-26a-5p inhibits proliferation, invasion and metastasis by repressing the expression of Wnt5a in papillary thyroid carcinoma</p>. OncoTargets and Therapy. Volume 12. 6605–6616. 35 indexed citations
7.
Ding, Mingjian, et al.. (2018). Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/β-catenin signaling pathway. Biomedicine & Pharmacotherapy. 105. 848–855. 17 indexed citations
8.
9.
Li, Weili, Wenzhe Wang, Mingjian Ding, et al.. (2016). MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin. Cancer Cell International. 16(1). 30–30. 43 indexed citations
10.
Ding, Mingjian, et al.. (2016). miR-935 promotes gastric cancer cell proliferation by targeting SOX7. Biomedicine & Pharmacotherapy. 79. 153–158. 34 indexed citations
11.
Wang, Wenzhe, Weili Li, Mingjian Ding, et al.. (2016). Identification of miRNAs as non-invasive biomarkers for early diagnosis of lung cancers. Tumor Biology. 37(12). 16287–16293. 12 indexed citations
12.
Ding, Mingjian, et al.. (2016). Association between transforming growth factor-β1 expression and the clinical features of triple negative breast cancer. Oncology Letters. 11(6). 4040–4044. 27 indexed citations
13.
Jia, Jing, Wenzhe Wang, Wen Meng, et al.. (2014). Development of a Multiplex Autoantibody Test for Detection of Lung Cancer. PLoS ONE. 9(4). e95444–e95444. 32 indexed citations
14.
15.
Cong, Xiaodong, You Wu, De‐Zai Dai, et al.. (2012). Activation of AQP4, p66Shc and endoplasmic reticulum stress is involved in inflammation by carrageenan and is suppressed by argirein, a derivative of rhein. Journal of Pharmacy and Pharmacology. 64(8). 1138–1145. 14 indexed citations
16.
Cong, Xiaodong, Mingjian Ding, De‐Zai Dai, et al.. (2011). ER Stress, P66shc, and P-Akt/Akt Mediate Adjuvant-Induced Inflammation, Which Is Blunted by Argirein, a Supermolecule and Rhein in Rats. Inflammation. 35(3). 1031–1040. 48 indexed citations
17.
Cao, Gang, Yun Zhang, Jian Feng, et al.. (2011). A Rapid and Sensitive Assay for Determining the Main Components in Processed Fructus Corni by UPLC–Q-TOF-MS. Chromatographia. 73(1-2). 135–141. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Élisabeth Miot-Noirault Breakdown of academic impact, for papers by Juan Zou Breakdown of academic impact, for papers by Xiaoguo H. Zhan Breakdown of academic impact, for papers by Jin Cao Breakdown of academic impact, for papers by Yong‐Tark Jeon Breakdown of academic impact, for papers by Eun-Yeong Kim Breakdown of academic impact, for papers by Xiu Cheng Breakdown of academic impact, for papers by Tong Xu
Rankless by CCL
2026